Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency (Q39351060)
Jump to navigation
Jump to search
scientific article published on 9 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency |
scientific article published on 9 May 2012 |
Statements
1 reference
Sensitivity of glioblastomas to clinically available MEK inhibitors is defined by neurofibromin 1 deficiency (English)
1 reference
Wendy L See
1 reference
I-Li Tan
1 reference
Joydeep Mukherjee
1 reference
Theodore Nicolaides
1 reference
Russell O Pieper
1 reference
9 May 2012
1 reference
1 reference
72
1 reference
13
1 reference
3350-3359
1 reference
Identifiers
1 reference
1 reference
1 reference